Private Ab Tomeqt serves as Executive at DiaMedica Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Private Ab Tomeqt has executed 1 insider transactions totaling $5.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 23, 2023 involved purchasing 1,470,588 shares valued at $5.0M.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jun 23, 2023 | DMAC | $5.0M | Purchase | 1,470,588 | $3.40 | Discretionary |
Private Ab Tomeqt currently holds 4,326,435 shares of DiaMedica Therapeutics Inc. (DMAC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Private Ab Tomeqt has been a net buyer of DMAC stock. They have purchased $5.0M and sold $0 worth of shares.
Private Ab Tomeqt's most recent insider trade was on Jun 23, 2023, when they purchased 1,470,588 shares at $3.40 per share.
Get notified when new Form 4 filings are submitted